Home > Publications database > Innovative strategies for modeling peptide–protein interactions and rational peptide drug design > print

001     1043697
005     20250804202237.0
024 7 _ |a 10.1016/j.sbi.2025.103083
|2 doi
024 7 _ |a 0959-440X
|2 ISSN
024 7 _ |a 1879-033X
|2 ISSN
024 7 _ |a 10.34734/FZJ-2025-02991
|2 datacite_doi
024 7 _ |a 40570517
|2 pmid
024 7 _ |a WOS:001523231900001
|2 WOS
037 _ _ |a FZJ-2025-02991
082 _ _ |a 570
100 1 _ |a Scharbert, Lara
|0 P:(DE-Juel1)185030
|b 0
|u fzj
245 _ _ |a Innovative strategies for modeling peptide–protein interactions and rational peptide drug design
260 _ _ |a Amsterdam [u.a.]
|c 2025
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1752738465_1013
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a This review highlights cutting-edge techniques for modeling peptide–protein interactions and advancing computer-aided peptide–drug design. We examine significant progress in generating peptide poses through docking and artificial intelligence (AI), assessing peptide flexibility via enhanced molecular dynamics simulations, and analyzing binding interactions through free energy calculations. Additionally, we discuss how these insights can inform the rational design of therapeutic peptides by utilizing free energy metrics and strategic modifications to enhance their binding affinity and therapeutic potential. Looking forward, further integrating AI will be crucial for optimizing peptide design and enhancing drug development efforts.
536 _ _ |a 5241 - Molecular Information Processing in Cellular Systems (POF4-524)
|0 G:(DE-HGF)POF4-5241
|c POF4-524
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Strodel, Birgit
|0 P:(DE-Juel1)132024
|b 1
|e Corresponding author
773 _ _ |a 10.1016/j.sbi.2025.103083
|g Vol. 93, p. 103083 -
|0 PERI:(DE-600)2019233-2
|p 103083 -
|t Current opinion in structural biology
|v 93
|y 2025
|x 0959-440X
856 4 _ |u https://juser.fz-juelich.de/record/1043697/files/1-s2.0-S0959440X25001010-main.pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:1043697
|p openaire
|p open_access
|p OpenAPC_DEAL
|p driver
|p VDB
|p openCost
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)185030
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)132024
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-524
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Molecular and Cellular Information Processing
|9 G:(DE-HGF)POF4-5241
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-09
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-09
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CURR OPIN STRUC BIOL : 2022
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-09
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-09
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-09
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CURR OPIN STRUC BIOL : 2022
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1120
|2 StatID
|b BIOSIS Reviews Reports And Meetings
|d 2024-12-09
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-09
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2024-12-09
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-09
915 p c |a APC keys set
|2 APC
|0 PC:(DE-HGF)0000
915 p c |a Local Funding
|2 APC
|0 PC:(DE-HGF)0001
915 p c |a DFG OA Publikationskosten
|2 APC
|0 PC:(DE-HGF)0002
915 p c |a DEAL: Elsevier 09/01/2023
|2 APC
|0 PC:(DE-HGF)0125
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)IBI-7-20200312
|k IBI-7
|l Strukturbiochemie
|x 0
980 1 _ |a FullTexts
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)IBI-7-20200312
980 _ _ |a APC

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21